CU-10101
/ Cutia Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 21, 2025
A Phase I Clinical Trial to Evaluate CU-10101 Unguent
(clinicaltrials.gov)
- P1 | N=64 | Enrolling by invitation | Sponsor: Cutia Therapeutics（Wuxi）Co.,Ltd | Trial completion date: Sep 2025 ➔ Sep 2026 | Trial primary completion date: Sep 2025 ➔ Sep 2026
Trial completion date • Trial primary completion date • Atopic Dermatitis • Dermatitis • Dermatology • Immunology
1 to 1
Of
1
Go to page
1